Cash Flow Statement
Growth Metrics

Biolife Solutions (BLFS) Gross Margin (2010 - 2026)

Biolife Solutions (BLFS) reported Gross Margin of 63.62% for Q1 2026, down 349.0% year-over-year from 25.55% in Q1 2025, and up 260.33% on a QoQ basis from 39.68% in Q4 2025.

Biolife Solutions (BLFS) has 17 years of Gross Margin data on file, last reported at 63.62% in Q1 2026.

  • Quarterly Gross Margin fell 349.0% year-over-year to 63.62% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 58.4% (down 400.0% YoY) and the FY2025 annual result came in at 64.56%, down 255.0% from the prior year.
  • Gross Margin rose to 63.62% in Q1 2026 per BLFS's latest filing, from 39.68% in the prior quarter.
  • Across five years, Gross Margin topped out at 199.94% in Q4 2023 and bottomed at 39.68% in Q4 2025.
  • The 5-year median for Gross Margin is 86.9% (2023), against an average of 77.65%.
  • The widest annual swing landed in 2023, when Gross Margin surged 10946 bps; it then plunged 21368 bps in 2024.
  • Tracing BLFS's Gross Margin over 5 years: stood at 90.48% in 2022, then jumped by 121 bps to 199.94% in 2023, then sank by 107 bps to 13.75% in 2024, then slumped by 189 bps to 39.68% in 2025, then surged by 260 bps to 63.62% in 2026.
  • Per Business Quant, the three latest BLFS Gross Margin figures stand at 63.62% (Q1 2026), 39.68% (Q4 2025), and 90.99% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 66.06%
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn 45.69%
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 62.25%
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 35.08%
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn 54.66%
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 67.88%
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 70.82%
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn 32.99%
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 35.80%
10 Biolife Solutions 1.20 Bn 1.12 Bn 17.50 Mn 63.62%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 63.62%
Dec 31, 2025 -39.68%
Sep 30, 2025 90.99%
Jun 30, 2025 89.25%
Mar 31, 2025 67.11%
Dec 31, 2024 -13.75%
Sep 30, 2024 88.28%
Jun 30, 2024 87.41%
Mar 31, 2024 87.11%
Dec 31, 2023 199.94%
Sep 30, 2023 79.32%
Jun 30, 2023 86.90%
Mar 31, 2023 82.84%
Dec 31, 2022 90.48%
Sep 30, 2022 87.05%
Jun 30, 2022 86.64%
Mar 31, 2022 86.50%
Dec 31, 2021 87.19%
Sep 30, 2021 87.97%
Jun 30, 2021 89.93%
Mar 31, 2021 88.00%
Dec 31, 2020 87.21%
Sep 30, 2020 85.92%
Jun 30, 2020 86.23%
Mar 31, 2020 87.04%
Dec 31, 2019 79.88%
Sep 30, 2019 68.44%
Jun 30, 2019 70.78%
Dec 31, 2018 68.66%
Sep 30, 2018 69.66%
Jun 30, 2018 70.32%
Dec 31, 2017 58.69%
Sep 30, 2017 63.02%
Jun 30, 2017 62.59%
Mar 31, 2017 60.76%
Dec 31, 2016 60.73%
Sep 30, 2016 56.87%
Jun 30, 2016 56.14%
Mar 31, 2016 58.37%
Dec 31, 2015 62.63%
Sep 30, 2015 59.65%
Jun 30, 2015 54.69%
Mar 31, 2015 58.81%
Sep 30, 2014 47.32%
Mar 31, 2014 43.75%
Mar 31, 2013 52.11%
Dec 31, 2012 36.78%
Sep 30, 2012 35.52%
Jun 30, 2012 41.71%
Mar 31, 2012 9,795.02%
Dec 31, 2011 56.81%
Sep 30, 2011 52.07%
Jun 30, 2011 53.61%
Mar 31, 2011 39.65%
Dec 31, 2010 -14.09%
Sep 30, 2010 43.25%
Jun 30, 2010 3,872.36%